Sign in
4

Changes in Ownership

Anebulo Pharmaceuticals, Inc. Filed Acc 0001493152-24-024122

Options or other derivatives

  • Director acquired 44,976 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SHAH BIMAL R. Director 2024-06-13 Grant or award · Stock Option (right to buy) +41,667 41,667 D
SHAH BIMAL R. Director 2024-06-13 Grant or award · Stock Option (right to buy) +3,309 3,309 D
Loading xslF345X05/ownership.xml…